P

Palvella Therapeutics Inc
D

PVLA

102.870
USD
2.98
(2.98%)
مفتوح الان
حجم التداول
5,506
الربح لكل سهم
-4
العائد الربحي
-
P/E
-41
حجم السوق
1,217,619,726
المقالات

العنوان: Palvella Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.